Altre lingue Galera Therapeutics, Inc.

Azioni

GRTX

US36338D1081

Mercato chiuso - OTC Markets Altri mercati azionari 21:58:34 28/06/2024			Variaz. 5gg	Var. 1 gen.
0,1368 ^USD	+1,33%		+61,89%	-5,91%

07/06	Galera Therapeutics, Inc. elimina Robert A. Beardsley come Direttore operativo	CI
03/06	Wall Street si appresta ad aprire in leggero rialzo lunedì, mentre gli investitori attendono i dati manifatturieri chiave per maggio	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Galera Therapeutics, Inc. Eliminates Robert A. Beardsley as Chief Operating Officer	07/06
Galera Therapeutics, Inc.(OTCPK:GRTX) dropped from S&P TMI Index	06/06
Wall Street Set to Open Slightly Higher Monday as Investors Await Key Manufacturing Data for May	03/06
Top Premarket Decliners	03/06
Galera Therapeutics : Failure to Satisfy Listing Rule - Form 8-K	03/06
Galera Therapeutics, Inc.(OTCPK:GRTX) dropped from NASDAQ Composite Index	03/06
Galera Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates	13/05
Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates	13/05
Galera Adopts Limited Duration Stockholder Rights Agreement	03/05
North American Morning Briefing : Powell Awaited -2-	03/04
Galera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Galera Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/03
Galera Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Updates	28/03
Galera Therapeutics : Failure to Satisfy Listing Rule - Form 8-K	27/03
North American Morning Briefing : Markets on Hold -2-	20/03
North American Morning Briefing : Stock Futures -2-	13/03
Galera Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates	14/11
Galera Reports Third Quarter 2023 Financial Results and Recent Corporate Updates	14/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Galera Therapeutics, Inc.

Azioni

GRTX

US36338D1081

Altre lingue

Filtri